Educational Seminars & Annual Meeting
|Phyllis Flomenberg, MD, TJU, Jefferson Medical College||February||2/9/08||"Human T cell responses to vaccinia vaccine."|
|Takami Sato, MD, TJU, Jefferson Medical College||March||3/11/08||"Immunoembolization of Hepatic Metastatis-InSitu Cancer Vaccine for Metastaic Uval Melanoma"|
|Bernhard Dietzschold, DVM, TJU, Jefferson Medical College||April||4/15/08||"Strategies to develop safe and efficacious live recombinant rabies vaccines"|
|David Cooper, PhD Wyeth Vaccine Research, NY||May||5/9/08||"Development of vaccine vectors based on vesicular stomatitis virus"|
|Ana Fernandez-Sesma, PhD, Mount Sinai School of Medicine, New York||September||9/26/08||"Initiation of antiviral immunity by human dendritic cells|
|Vitali Alexeev, PhD, TJU, Jefferson Medical College||October||10/24/08||"Chemokine-mediated tumor immuno-targeting"|
|Kishore Alugupalli, PhD, TJU, Jefferson Medical College||November||11/19/08||"That's why children do not respond to polysaccharide vaccines"|
|David B. Weiner, Ph.D, University of Pennsylvania||January||1/23/09||"STEPing up after STEP: a second look at DNA vaccine technology"|
|Marcia A. Blackman, PhD, Trudeau Institute||September||9/18/09||"The impact of aging on T cell repertoire and immunity to influenza virus: lessons from the mouse"|
PhD Thesis - Work in Progress
|2/21/08||Celestine Wanjalla||Dendritic Cell-based HIV Vaccines|
|10/15/08||Sanda Chhann||Mechanisms of CD8+ T cell Protective Immunity|
|12/17/08||Gregory Dickinson||Intracellular Pattern-Recognition Receptors in Septic Shock: a Fresh New Perspective|
|2/18/09||Sandra Bonne-Annee||The Role of Macrophages in the Fight Against Extracellular Parasites|
|3/18/09||Emily Sheston||Examining the Immunogenicity of a Single-cycle Rabies Virus Vector|
|4/15/09||Nicholas A. Siciliano||The Impact of ER Stress on Cellular Immunity|
Vaccine Center Third Annual Meeting
The Jefferson Vaccine Center's Annual Meeting will be announced in January 2010.
Jefferson Vaccine Center Annual Meeting Itinerary
Click here to download the 2009 Jefferson Vaccine Center Annual Meeting Itinerary (Adobe PDF).
In the News
New Funding for JVC Members
Dr. McGettigan, was awarded a four-year $1.5 million R01 grant from the NIH to extend his exciting work on the development of a novel, safe, and effective rabies virus vaccine.
A Team of Researchers from Fox Chase, Jefferson and Penn State Receive NIAID Grant for Viral Control. Both Dr. Luis Sigal and Dr. Eisenlohr are members of the JVC. The team to receive a total of approximately $2 million each year for the next five years. For more information ...
Dr. David Abraham received a five year R01 grant to study the development of a recombinant vaccine against human onchocerciasis.